(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
OptiBiotix Health PLC - York, England-based life sciences firm - Shares begin trading on the OTCQB Venture Market in the US at Thursday's market open under the symbol OPTBF. Notes this will not impact shares trading on the AIM Market in London. "OptiBiotix is building its consumer presence in the USA as shown by the recent launch of its appetite reducing SlimBiome in Hydroxycut, the [number] 1 selling weight loss supplement brand in the USA," says Chief Executive Officer Stephen O'Hara. "This follows on from launches earlier this year with new US partners such as NHT and Daily Nouri. As we increase our brand presence in the USA the board believe joining the OTCQB Market will help increase our visibility to the US investment community, broadening our shareholder base and improving liquidity." Read More
(Alliance News) - OptiBiotix Health PLC on Wednesday said it has signed a distribution agreement with a "well-known" and "established" weight management company, as it noted shifting consumer sentiment in the market. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More
(Alliance News) - OptiBiotix Health PLC on Monday said it continues to grow its top line and improve margins, as investments open up a multi territory revenue stream. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Stock prices in London closed in the red on Friday, following US President Donald Trump's renewed tariff threats against the EU and Apple. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and last week and not separately reported by Alliance News: Read More
OptiBiotix Health PLC - York-based life sciences firm - Says Finance Director Graham Myers will step down on November 30 and be replaced by David Blain, who will join as acting Finance Director on November 1. David Blain is currently financial director at Iksuda Therapeutics Ltd. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by Alliance News: Read More
ProBiotix Health PLC - Wakefield, England-based life sciences business developing probiotics to tackle cardiovascular disease and other lifestyle conditions - OptiBiotix Health PLC, a York-based life sciences peer and major shareholder of ProBiotix, says it will vote in favour of the resolutions put forward by fellow shareholder Seneca Partners. ProBiotix on Wednesday confirmed it had received a requisition notice from a nominee of 5.5% shareholder Seneca, calling for a general meeting to vote on proposals to remove two ProBiotix directors, including Chief Executive Officer Steen Andersen. ProBiotix said all of its directors, other than Stephen O'Hara, who also is chief executive of OptiBiotix, support keeping both directors in place. Read More
(Alliance News) - ProBiotix Health PLC on Friday defended the validity of its recent GBP1.2 million fundraise, despite protestations from shareholder OptiBiotix Health PLC. Read More
(Alliance News) - OptiBiotix Health PLC on Tuesday said it was confident in its outlook as it was gaining commercial traction with large partners. Read More
OptiBiotix Health PLC - York, England-based life sciences company - On Thursday, notes that study outcomes at Roehampton University in London suggested the company's SlimBiome "had a major impact on insulin response combined with significantly lower feelings of hunger, a lower desire to eat, and significantly higher levels of fullness within 15 minutes, for over two hours after consumption". Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - OptiBiotix Health PLC on Monday said it has raised GBP1.4 million through a placing and subscription of shares. Read More